Skip to content

Effect of a Risk-Based Perioperative Pressure Injury Prevention Bundle in Elective Surgery Patients

Effect of a Risk-Based Perioperative Pressure Injury Prevention Bundle on Pressure Injury Development in Patients Undergoing Elective Surgery: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07725068
Acronym
RiPPB
Enrollment
138
Registered
2026-07-24
Start date
2026-08-01
Completion date
2026-12-30
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Braden Scale, Perioperative Care, Pressure Injury Prevention, Pressure Ulcer (PU)

Keywords

Surgical Wound, risk assessment

Brief summary

This study evaluates whether a risk-based perioperative pressure injury prevention bundle reduces the development of pressure injuries in patients undergoing elective surgery lasting 3 hours or longer. Pressure injuries that develop during and after surgery are a common patient safety problem, especially in older adults and in longer procedures. In this randomized controlled trial, patients will be assigned by chance to either an intervention group or a control group. In the intervention group, each patient's pressure injury risk will be assessed before surgery using the Braden Scale together with additional perioperative risk factors, and patients will then receive one of three prevention bundles matched to their risk level (low, moderate, or high). The high-risk bundle includes prophylactic silicone foam dressings on the sacrum and heels, targeted positioning, and pressure-redistributing support surfaces. The control group will receive standard perioperative care without risk-based bundling, although Braden Scale assessment will still be performed. Skin assessments will be conducted at four time points: before surgery, in the post-anesthesia care unit, at 2-4 hours after surgery, and at 24 hours after surgery. The main outcome is whether patients develop early signs of pressure injury, including non-blanchable erythema, within the first 24 postoperative hours. The study hypothesizes that patients receiving the risk-based prevention bundle will have a lower incidence of postoperative pressure injury and non-blanchable erythema compared with patients receiving standard care.

Detailed description

This is a prospective, two-arm, parallel-group randomized controlled trial conducted according to the CONSORT 2025 guideline. Participants will be enrolled from orthopedic, general surgery, urology, and neurosurgery services at a single center. Block randomization with concealed allocation (sealed envelopes) will be used to assign participants to the intervention or control arm in a 1:1 ratio. In the intervention arm, risk stratification will be based on the Braden Scale score combined with additional perioperative risk factors (e.g., surgical duration, ASA class, intraoperative hypotension or hypothermia, surgical position). Patients will be categorized into low-, moderate-, or high-risk subgroups, each receiving a distinct prevention bundle consisting of positioning strategies, support-surface selection, and, for high-risk patients, prophylactic silicone foam dressings. Data will be collected using a study-specific instrument developed based on the 2025 EPUAP/NPIAP/PPPIA Pressure Injury Prevention Guideline, consisting of a demographic/clinical data section, the Braden Scale, a bundle-implementation checklist (intervention arm only), and a skin assessment outcome form completed at all four time points for both arms. Data will be analyzed using SPSS, with chi-square tests for categorical variables, independent-samples t-tests for continuous variables, and logistic regression to control for potential confounding by Braden score.

Interventions

OTHERRisk-Based Perioperative Pressure Injury Prevention Bundle

A three-tier prevention bundle (low, moderate, high risk), tailored to each patient's Braden Scale score combined with additional perioperative risk factors. The high-risk tier includes prophylactic silicone foam dressings applied to the sacrum and heels, targeted intraoperative positioning, and pressure-redistributing support surfaces; the moderate-risk tier includes targeted padding/off-loading and support-surface optimization; the low-risk tier includes routine positioning and standard support-surface use. Skin assessment is conducted at four perioperative time points.

Sponsors

Acibadem University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Participants are randomly allocated in a 1:1 ratio to either the risk-based perioperative pressure injury prevention bundle (intervention arm) or standard perioperative care (control arm), and followed in parallel through four assessment time points (preoperative, PACU, 2-4 hours postoperative, and 24 hours postoperative).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Scheduled to undergo elective orthopedic, general, neurosurgical, or urological surgery * Anticipated surgical duration greater than 3 hours * No pressure injury present preoperatively * Willing and able to provide informed consent to participate

Exclusion criteria

* Existing pressure injury at enrollment * Undergoing emergency surgery * Known allergy to dressing/adhesive materials used in the prevention bundle * Severe dermatological condition affecting skin integrity * Unplanned postoperative intensive care unit admission

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Postoperative Pressure InjuryAssessed at 24 hours after surgery (T3)Development of a pressure injury (including non-blanchable erythema) at any assessed anatomical site (sacrum, right/left heel, occiput, scapula, elbow, right/left trochanter, right/left malleolus, or other site), assessed via skin examination and recorded as Yes/No.

Secondary

MeasureTime frameDescription
Number of Anatomical Sites at RiskAssessed at 24 hours after surgery (T3)Count of anatomical sites (sacrum, heels, occiput, scapula, elbows, trochanters, malleoli, and other sites) showing signs of pressure injury or non-blanchable erythema per participant.
Protocol AdherenceAssessed throughout the perioperative period, from preoperative (T0) through 24 hours postoperative (T3)Proportion of prevention bundle components (positioning, support surface use, prophylactic dressing application) delivered as specified for each risk-level tier in the intervention arm, recorded as Yes/No for each component.
Incidence of Non-Blanchable ErythemaAssessed preoperatively (T0), in the post-anesthesia care unit (T1), at 2-4 hours postoperative (T2), and at 24 hours postoperative (T3)Presence of non-blanchable erythema (early sign of pressure injury) at any assessed anatomical site, recorded as Yes/No.

Countries

Turkey (Türkiye)

Contacts

CONTACTHilal Y Çelik, Lecturer, PhD
hilal.yildiz@acibadem.edu.tr+90 02165004172
STUDY_DIRECTORAyper Önal Alkan, RN, PhD,

Acıbadem Mehmet Ali Aydınlar University

PRINCIPAL_INVESTIGATORUkke Karabacak, Professor

Acıbadem Mehmet Ali Aydınlar University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026